Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Investing Ideas
Browse All Stocks
Markets
Investing Ideas
›
Top Stock Picks from Analysts
Edit Screener
Get New Stock Alert
Top Stock Picks from Analysts
Results
38
1 new
Companies which are more than 50% undervalued based on analyst price target.
🇭🇰 HK Market
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Pharmaceuticals & Biotech
All Industries
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
38 companies
1 new company last 7d
Company
Last Price
7D Return
1Y Return
Market Cap
Analysts Target
Valuation
Growth
Div Yield
1177
Sino Biopharmaceutical
HK$5.39
10.7%
-30.2%
HK$96.0b
HK$8.27
PE
34.4
E
17.4%
2.6%
9926
Akeso
HK$93.90
-9.4%
-44.1%
HK$86.5b
HK$167.82
PS
24.3
E
46.0%
n/a
1530
3SBio
HK$16.50
-7.2%
-46.6%
HK$41.1b
HK$32.73
PE
4.2
E
-40.1%
1.5%
3696
InSilico Medicine Cayman TopCo
HK$44.20
-4.7%
n/a
HK$25.3b
HK$80.70
PS
57.4
E
115.0%
n/a
512
Grand Pharmaceutical Group
HK$5.48
2.9%
-43.7%
HK$19.2b
HK$11.90
PE
15.5
E
17.3%
3.1%
7666
Metis TechBio
HK$15.00
13.7%
n/a
HK$17.7b
HK$24.45
PS
144.8
E
80.8%
n/a
3933
United Laboratories International Holdings
HK$8.72
-2.6%
-48.3%
HK$17.2b
HK$15.05
PE
7.1
E
7.3%
5.6%
9606
Duality Biotherapeutics
HK$187.70
-2.2%
-43.3%
HK$17.0b
HK$423.06
PS
7.9
E
89.8%
n/a
6185
CanSino Biologics
HK$32.06
26.0%
-34.3%
HK$12.8b
HK$50.45
PS
6.1
E
57.2%
0%
6855
Ascentage Pharma Group International
HK$33.60
-9.5%
-62.7%
HK$12.4b
HK$81.96
PS
18.5
E
58.6%
n/a
2595
GenFleet Therapeutics (Shanghai)
HK$32.74
4.2%
n/a
HK$12.1b
HK$50.68
PS
79.8
E
77.6%
n/a
1681
Consun Pharmaceutical Group
HK$13.66
-0.9%
-3.1%
HK$11.5b
HK$23.54
PE
9.1
E
11.2%
5.9%
1672
Ascletis Pharma
HK$10.25
-4.3%
-25.5%
HK$10.8b
HK$23.88
PS
4576.9
E
-23.9%
n/a
6938
Suzhou Ribo Life Science
HK$51.50
-4.6%
n/a
HK$8.8b
HK$103.22
PS
50.7
E
-9.8%
n/a
2616
CStone Pharmaceuticals
HK$5.45
-5.9%
-40.2%
HK$8.7b
HK$14.28
PS
27.7
E
76.7%
n/a
2186
Luye Pharma Group
HK$2.15
1.4%
-42.3%
HK$8.6b
HK$3.51
PE
11.9
E
18.4%
0%
460
Sihuan Pharmaceutical Holdings Group
HK$0.91
4.0%
-38.4%
HK$8.2b
HK$2.00
PE
39.0
E
49.2%
2.5%
2256
Abbisko Cayman
HK$10.60
-2.4%
-36.7%
HK$7.6b
HK$21.63
PE
117.8
E
-73.9%
n/a
3613
Beijing Tong Ren Tang Chinese Medicine
HK$6.42
-2.4%
-30.9%
HK$5.4b
HK$10.25
PE
13.5
E
18.4%
5.8%
6915
New
Jiangxi Institute of Biological Products
HK$15.28
5.0%
n/a
HK$4.7b
HK$23.60
PE
42.6
S
37.6%
n/a
1477
Ocumension Therapeutics
HK$5.32
-0.09%
-55.7%
HK$4.3b
HK$9.56
PS
4.6
E
94.6%
n/a
1666
Tong Ren Tang Technologies
HK$3.32
-0.2%
-36.9%
HK$4.3b
HK$5.27
PE
9.2
E
12.4%
6.3%
2617
TransThera Sciences (Nanjing)
HK$10.38
-2.6%
-81.1%
HK$4.2b
HK$18.70
PB
8.7
E
34.3%
n/a
1167
Jacobio Pharmaceuticals Group
HK$5.30
-1.1%
-36.4%
HK$4.2b
HK$9.80
PS
66.5
S
9.8%
n/a
Page 1 of 2
Dashboard
Portfolios
Watchlist
Community
Discover
Screener
EN